Abstract
Evidence-based review of the existing literature ultimately recommends stocking of Methylene Blue (MB) as an emergency antidote in the United States. The same is reported around the world in Japan, Greece, Italy and Canada. The observation that MB is always present as the main antidote required in emergency and critical care units calls for a revisit on its effects on the NO/cGMP system to reemphasize its multisystem actions. Therefore, the present review aimed to display the role of MB in emergency units, concerning: 1) Polytrauma and circulatory shock; 2) Neuroprotection, 3) Anaphylaxis and, 4) Overdose and poisoning.
Keywords: Methylene blue, cGMP, nitric oxide, circulatory shock, neuroprotection, anaphylaxis, poisoning.
Current Drug Targets
Title:Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes
Volume: 19 Issue: 13
Author(s): Caroline F. Baldo, Luiza M. Silva, Livia Arcencio, Agnes A.S. Albuquerque, Andrea C. Celotto, Anibal Basile-Filho and Paulo R.B. Evora*
Affiliation:
- Department of Surgery and Anatomy, Ribeirao Preto School of Medicine, University of Sao Paulo, SP,Brazil
Keywords: Methylene blue, cGMP, nitric oxide, circulatory shock, neuroprotection, anaphylaxis, poisoning.
Abstract: Evidence-based review of the existing literature ultimately recommends stocking of Methylene Blue (MB) as an emergency antidote in the United States. The same is reported around the world in Japan, Greece, Italy and Canada. The observation that MB is always present as the main antidote required in emergency and critical care units calls for a revisit on its effects on the NO/cGMP system to reemphasize its multisystem actions. Therefore, the present review aimed to display the role of MB in emergency units, concerning: 1) Polytrauma and circulatory shock; 2) Neuroprotection, 3) Anaphylaxis and, 4) Overdose and poisoning.
Export Options
About this article
Cite this article as:
Baldo F. Caroline, Silva M. Luiza, Arcencio Livia, Albuquerque A.S. Agnes, Celotto C. Andrea, Basile-Filho Anibal and Evora R.B. Paulo*, Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes, Current Drug Targets 2018; 19 (13) . https://dx.doi.org/10.2174/1389450119666180403100410
DOI https://dx.doi.org/10.2174/1389450119666180403100410 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design A Discussion of Natural Rubber Latex Allergy with Special Reference to Children: Clinical Considerations
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Diabetes and Nutritional Screening in Post-Bariatric Patients
Current Diabetes Reviews Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?
CNS & Neurological Disorders - Drug Targets Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review
Current Organic Chemistry Effective Use of Drugs to Counter Chemical Terrorism
Current Drug Therapy Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Pegfilgrastim-Apgf (Nyvepria): Biosimilar USFDA Approval for the Treatment of Chemotherapy-induced Febrile Neutropenia and Current Updates on Clinical Trials
Current Drug Targets Efficacy and Safety of Nonopioid Analgesics in Perioperative Pain Control
Current Drug Safety Medical Management of the Diabetic Patient with Coronary Artery Disease
Current Pharmaceutical Design Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
Current Drug Safety Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease
Current Neuropharmacology QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Current Drug Safety Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction?
Current Diabetes Reviews Neurotoxicity of Insecticides
Current Medicinal Chemistry Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Current Pharmaceutical Design Under-Dosing of Etomidate for Rapid Sequence Intubation in the Emergency Department
Current Drug Safety Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Exploring the Therapeutic Potential of <i>Chrysanthemum morifolium</i>: An Ethnopharmacological Perspective
Current Nutrition & Food Science